Overview of legal regulation of pharmaceutical business in the Republic of Belarus 2023
REVERA lawyers have prepared a review, in which you will find up-to-date information on the state of the pharmaceutical market in Belarus, as well as on the peculiarities of circulation and sale of medicines not only in Belarus, but also in the EAEU.
The material will allow you to form a comprehensive understanding of the pharmaceutical industry, from the general characterisation of the Belarusian market to the protection of rights to medicines in the Republic of Belarus.
The prepared overview will be useful for pharmaceutical companies that consider Belarus as a market for setting up pharmaceutical production and marketing their medicines in the Eurasian Economic Union market with a population of 185 million people.
Download the overviewDear journalists, the use of materials from REVERA website in publications is possible only after our written permission.
For approval of materials please contact e-mail: i.antonova@revera.legal or Telegram: https://t.me/PR_revera
